KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Restructuring Costs: 2009-2024

Historic Restructuring Costs for Thermo Fisher Scientific (TMO) over the last 16 years, with Dec 2024 value amounting to $379.0 million.

  • Thermo Fisher Scientific's Restructuring Costs rose 200.00% to $135.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $543.0 million, marking a year-over-year increase of 135.06%. This contributed to the annual value of $379.0 million for FY2024, which is 17.43% down from last year.
  • Per Thermo Fisher Scientific's latest filing, its Restructuring Costs stood at $379.0 million for FY2024, which was down 17.43% from $459.0 million recorded in FY2023.
  • Over the past 5 years, Thermo Fisher Scientific's Restructuring Costs peaked at $459.0 million during FY2023, and registered a low of $99.0 million during FY2020.
  • Its 3-year average for Restructuring Costs is $317.3 million, with a median of $379.0 million in 2024.
  • As far as peak fluctuations go, Thermo Fisher Scientific's Restructuring Costs tumbled by 42.13% in 2022, and later spiked by 302.63% in 2023.
  • Thermo Fisher Scientific's Restructuring Costs (Yearly) stood at $99.0 million in 2020, then skyrocketed by 98.99% to $197.0 million in 2021, then tumbled by 42.13% to $114.0 million in 2022, then spiked by 302.63% to $459.0 million in 2023, then declined by 17.43% to $379.0 million in 2024.